Stock Events

Stock Events

Gain Therapeutics (GANX) Q1 2026 Earnings

26MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.19

-0.16

-0.14

-0.11

Details

Expected EPS

-0.144

Actual EPS

-0.11

Surprise EPS

0.03

Surprise Percent

+23.61%

Description

Gain Therapeutics (GANX) has reported earnings of -0.11 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.